8、编辑部信息：《转化神经科学电子杂志（英文）》更名为《转化神经病学与神经外科电子杂志（英文）》（Translational Neurology and Neurosurgery）
2026年4月22日星期三
《转化神经病学与神经外科电子杂志（英文）》稿约
【主办单位微信公众号信息】
首都医科大学学报2026年4月2日 18:00
为进一步拓展神经科学学科领域、强化临床转化特色，经主管部门批准，原《转化神经科学电子杂志（英文）》(Journal of Translational Neuroscience, JTN)自2025年起正式更名为《转化神经病学与神经外科电子杂志（英文）》(Translational Neurology and Neurosurgery, TNN)。
journal accepts the following article types: original research,
reviews, short communications, case reports, and others. We encourage
high-quality manuscripts that integrate basic and clinical research,
particularly in the areas of:
l Neural disease mechanisms
l Surgical innovation
l Neuroimaging
l Brain-machine interfaces
l Neurorehabilitation
l AI-assisted neuroscience
Priority
will be given to manuscripts with strong innovative and translational
value, especially those involving cross-disciplinary or international
collaborations.
2. Manuscript Structure
Articles should be organized into the following sections:
2.1 Title Page
l Full title: The title should be informative, specific to the project, yet concise (75 characters or fewer).
l Authors’ full names: Include all authors and their institutional affiliations in the order of contribution.
l Institutional affiliations: Include department names, institutions, cities, and countries.
l
Corresponding author: Name, full address (including postal code), and
email address (We strongly recommend that you use an institutional or
professional email address, e.g., from your university or organization,
rather than a QQ email address).
2.2 Abstract
For original research, reviews, short communications, case reports, and others, provide a structured abstract of ≤ 300 words, containing Objective, Method, Result, and Conclusion.
2.3 Keywords
For original research, reviews, short communications, case reports, and others:
l Provide up to 10 keywords, separated by semicolons.
l
We suggest that keywords do not replicate those used in the title. Use
specific terms that highlight the essential aspects of the study.
2.4 Main Text
URLs are not allowed to appear in main text.
2.4.1 Introduction
The
introduction should put the focus of the manuscript into a broader
context and should supply sufficient background information to allow the
reader to understand and evaluate the results without referring to
previous publications on the topic.
2.4.2 Methods
This
section should include sufficient technical information to enable the
experiments to be reproduced. Protocols for new methods or significant
modifications to existing methods should be included, while previously
published or well-established protocols should only be referenced.
2.4.3 Results
This
section should provide statistical analyses of all of the experiments
that are required to support the conclusions of the paper. Present the
results as concisely as possible in text, table(s), or figure(s). Avoid
extensive use of graphs to present data that might be more concisely
presented in the text or tables. Tables and figures should be numbered
consecutively using Arabic numerals and referred to in the text by
number, and be sure to cite all figures and tables. Please afford high
quality and high-resolution images. Tables should be typed as text,
please do not use graphics software to create tables.
2.4.4 Discussion
The
discussion should provide an interpretation of the results in relation
to previously published work and to the experimental system used. This
section should spell out the major conclusions of the work along with
some explanation or speculation on the significance of these
conclusions. The discussion should be concise and tightly argued.
2.5 Figures and Tables
● Resolution: Figures should be ≥ 300 dpi (JPEG/PNG), ≥ 600 dpi (line art).
●
Titles and Legends: Figures and tables must have descriptive titles and
legends. The first word and proper nouns should be capitalized.
● Editable files for figures and tables must be provided.
● URLs are not allowed to appear in figures or tables.
l Numbering and captions for composite figures:
—Primary figures (main figures): Use Figure 1, Figure 2, etc.
—Subfigures within a composite figure: Use (a), (b), (c), etc.
—Sub-subfigures (smaller units within a subfigure): Use (i), (ii), (iii), etc.
—The names and descriptions of subfigures should be included within the main figure caption.
—Descriptions
of the smallest units (i), (ii), ... should be placed in the figure
legend (note) directly below the main caption. Use a smaller or
different font, separate individual descriptions with semicolons, and
end the entire note with a period.
2.6 Acknowledgments
(if no, please write “Not applicable”)
2.7 Authors’ contributions
(Required)
2.8 Fundings
(if no, please write “Not applicable”)
2.9 Ethics approval and consent to participate
(Required)
Example:
The Research Ethics Commission of Beijing Tongren Hospital, Capital
Medical University (TRECKY2020–013) approved the study. All participants
provided written informed consent for an interview, as well as
follow-up interviews and blood sample collection.
And
for clinical trials, if the clinical research is registered on the
clinical research platform, please provide the platform name, and the
trial registration number.
If any of the above is not applicable to this study, please explain why.
2.10 Disclosure of artificial intelligence (AI) use
(Required)
If
any AI-assisted technologies (e.g., large language models, text
generators, coding assistants, image processors) were used in the
preparation of this work, the authors must explicitly declare:
l The name and version of the AI tool(s) used.
l The specific purpose(s) of use (e.g., language polishing, data analysis, image enhancement, literature summarization).
l The sections of the manuscript where AI was applied.
And
the authors must declare that “The authors are solely and fully
responsible for the entire content of this manuscript, including its
accuracy, integrity, and ethical compliance. The use of AI tools does
not diminish authorial responsibility.”
If no AI used, please state that “All authors declare that no AI was used in the writing and publication of this article.”
2.11 Competing interests
(Required)
Example: The authors declare that they have no competing interests.
2.12 Consent for publication
(Required)
Example:
All the authors consent to the publication of identifiable details,
which can include figures and data details within the text to be
published by Translational Neurology and Neurosurgery.
2.13 Data availability statement
(Required)
Example:
The raw data supporting the conclusions of this article will be made
available by the authors, without undue reservation/The data supporting
this study are available in [Repository Name] at [Accession Number]..
（if no, please write “Not applicable”）
2.14 References
No URLs (e.g., www, http, .com, .cn, etc.) are included. Please adhere to the following reference formatting guidelines:
l Provide complete information: Each reference should give readers enough details to locate the original article.
l Pay attention to formatting details: Please be mindful of spelling, capitalization, and punctuation.
l
Number references by order of citation: References should be numbered
in the order they first appear in the text; do not alphabetize them.
l
Use superscript numbers for citations: In the text, tables, and figure
legends, identify references with superscript Arabic numerals, e.g., [1,
6–10].
l Abbreviate journal titles: When listing references, abbreviate journal names according to the Index Medicus.
l
List authors correctly: For each reference, list the first three
authors; if there are additional authors, add "et al." after the third.
Reference Type
Example
Journal article-print
Salwachter
AR, Freischlag JA, Sawyer RG, et al. The training needs and priorities
of male and female surgeons and their trainees. J Am Coll Surg.
2005;201:199–205.
Journal article–online (from a database)
Calhoun
D, Trimarco T, Meek R, Locasto D. Distinguishing diabetes:
Differentiate between type 1 & type 2 DM. JEMS. November 2011;
36(11):32–48. Available from: CINAHL Plus with Full Text, Ipswich, MA.
Accessed February 2, 2012.
News–print
Wolf W. State’s mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004:1B.
News–online
Pollack A. FDA approves new cystic fibrosis drug. New York Times. January 31, 2012. Accessed February 1, 2012.
Web page
Outbreak
notice: Cholera in Haiti. Centers for Disease Control and Prevention
website. Published October 22, 2010. Updated January 9, 2012. Accessed
February 1, 2012.
Book
Modlin
J, Jenkins P. Decision Analysis in Planning for a Polio Outbreak in the
United States. San Francisco, CA: Pediatric Academic Societies; 2004.
Book chapter
Solensky
R. Drug allergy: desensitization and treatment of reactions to
antibiotics and aspirin. In: Lockey P, ed. Allergens and Allergen
Immunotherapy. 3rd ed. New York, NY: Marcel Dekker; 2004:585–606.
Authors are responsible for the accuracy and completeness of their references and for correct citation of the text.
3. Manuscript Submission
Please
submit your files in MS Word - standard DOCUMENT (.DOC) formats, and
recommend you upload your entire manuscript, including tables and
figures, as a single file. And please submit your files through the
journal’s submission system (https://mc.manuscriptcentral.com/tnn).
It
is important that authors include a cover letter with their manuscript.
The letter should contain all important details such as: your full name
(submitted by); full title of article; full list of authors with
affiliations (Affiliations should include: Department; University or
organization; City; Postal code; State/province; Country); e-mail of the
corresponding author; contact address, telephone/fax numbers of the
corresponding author.
4. Preprint Policy
● Manuscripts posted on non-peer-reviewed preprint servers (e.g., bioRxiv, medRxiv, arXiv, HEP Preprint) are accepted.
● Authors must disclose preprint details (DOI/URL) during submission.
